Results 81 to 90 of about 396 (132)

Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency. [PDF]

J Endocr Soc
Albers N, Cadarette S, Feakins B, Arregui M, Ebohon S, Lai P, Raveendran S, Kjelgaard-Hansen M, Andersen C, Zhao C, Smith A, Geffner M.   +11 more
europepmc   +1 more source

Efficacité et tolérance à long terme du somapacitan hebdomadaire chez les enfants présentant un déficit en hormone de croissance (GHD) : résultats à 7 ans de l’étude REAL 3

Benchikh, N, Højby, M, Saenger, P, Leunbach, T, Silverman, L, Horikawa, R, Sävendahl, L, Battelino, T   +7 more
core   +1 more source

EP1063 - ECE_1347 - Somapacitan in Japanese adults with growth hormone deficiency: an interim analysis of post-marketing surveillance

Shigeyuki Tahara, Shingo Fujio, Takaaki Endo, Fumio Otsuka, Anne Helene Olsen, Beverly M K Biller, Gudmundur Johannsson, Michael Højby, Hidenori Fukuoka   +8 more
core   +1 more source

Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group. [PDF]

Front Endocrinol (Lausanne)
Castro-Feijóo L, Labarta-Aizpún JI, Ramon-Krauel M, Primiano D, Yeste Fernández D, González Casado I.   +5 more
europepmc   +1 more source

The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA-Approved Drugs. [PDF]

J Clin Pharmacol
Bailey SL, Stern S, Dahmane E, Ramamoorthy A, Pacanowski M, Schuck R.   +5 more
europepmc   +1 more source

Efficacité et tolérance du somapacitan vs l’hormone de croissance (GH) quotidienne à 52 semaines chez des enfants présentant un déficit en hormone de croissance (GHD) : analyse poolée des études cliniques randomisées REAL 3, REAL 4 et REAL 6

Benchikh, N, Miller, BS, Højby, M, Fu, J, Wabitsch, M, Sävendahl, L, Maniatis, A, Mori, J, Pietropoli, A, Kelepouris, N   +9 more
core   +1 more source

Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial. [PDF]

Clin Pharmacokinet
Dombernowsky SL, Damholt BB, Højby Rasmussen M, Sværke C, Kildemoes RJ.   +4 more
europepmc   +1 more source

Efficacy, safety, and patient satisfaction of norditropin and sogroya in patients with growth hormone deficiency: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Endocrine
Altobaishat O, Abouzid M, Moawad MHED, Sharaf A, Al-Ajlouni Y, Umar TP, Bani-Salameh A, Tanashat M, Bataineh OA, Nashwan AJ.   +9 more
europepmc   +1 more source

Correction to: "Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement".

J Clin Endocrinol Metab
europepmc   +1 more source

Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement.

J Clin Endocrinol Metab
Maniatis A, Cutfield W, Dattani M, Deal C, Collett-Solberg PF, Horikawa R, Maghnie M, Miller BS, Polak M, Sävendahl L, Woelfle J.   +10 more
europepmc   +1 more source